Science Times Observer
SEE OTHER BRANDS

Your top news on science and technology

Science Times Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.

Press releases published on May 4, 2025

"Soul Licensed: Tips and Tales" Now Available on BookBub: Explore Spirit Messages and Inner Peace

"Soul Licensed: Tips and Tales" Now Available on BookBub: Explore Spirit Messages and Inner Peace

Tap into spirit guides, psychic insights, and daily divine messages with David Tuttle’s inspiring book. BRITISH COLUMBIA, VANCOUVER, CANADA, May 4, 2025 /⁨EINPresswire.com⁩/ -- ‘Soul Licensed: Tips and Tales’ by David Tuttle stands out as a potent …

PubHive Unveils AI-Powered Language Translation to Streamline Pharmacovigilance, Medical Affairs & Regulatory Workflows

PubHive Unveils AI-Powered Language Translation to Streamline Pharmacovigilance, Medical Affairs & Regulatory Workflows

PubHive introduces AI-powered translation to help life sciences teams streamline global safety reviews, literature review workflows, and compliance. LONDON, UNITED KINGDOM, May 4, 2025 /⁨EINPresswire.com⁩/ -- PubHive Ltd., a leading provider of cloud- …

Independent Non-Executive Director Appointed

Independent Non-Executive Director Appointed

PERTH, Australia, May 04, 2025 (GLOBE NEWSWIRE) -- Paladin Energy Ltd (ASX:PDN, TSX:PDN, OTCQX:PALAF) (Paladin or the Company) is pleased to announce the appointment of Anne Templeman-Jones as independent non-executive director of the Company. Ms Templeman …

Final Days to Submit Abstracts for the 2025 Lysosomal Disease Summit in Sydney, Australia

Final Days to Submit Abstracts for the 2025 Lysosomal Disease Summit in Sydney, Australia

Researchers Invited to Contribute to APAC’s Leading Lysosomal Disease Meeting SYDNEY, NSW, AUSTRALIA, May 4, 2025 /⁨EINPresswire.com⁩/ -- The 3rd Annual Lysosomal Disease Summit, to be held 24–26 October 2025 at the Hyatt Regency Sydney, invites …

Preliminary Phase 1b/2 Data for REC-4881 in Familial Adenomatous Polyposis (FAP) Demonstrates Reduced Polyp Burden

Preliminary Phase 1b/2 Data for REC-4881 in Familial Adenomatous Polyposis (FAP) Demonstrates Reduced Polyp Burden

In the Phase 2 open-label study, REC-4881 (4 mg QD) led to a median 43% reduction (n=6 patients) in polyp burden at the Week 13 assessment at time of data cutoff. Five of six patients (83%) experienced reductions in polyp burden ranging from 31% to 82%, …

Boly’s High Performance Concentrated Solar Products Move into Mass Production

Boly’s High Performance Concentrated Solar Products Move into Mass Production

MUNICH, May 03, 2025 (GLOBE NEWSWIRE) -- Boly Inc., a global high-tech company headquartered in Silicon Valley, is pleased to announce BolySolar® 3D, a revolutionary Solar Energy product, at Smart E Europe 2025 in Munich, May 7-10. By adopting patented 3D …

Konzentrierte Hochleistungs-Solarprodukte von Boly gehen in die Massenproduktion

Konzentrierte Hochleistungs-Solarprodukte von Boly gehen in die Massenproduktion

MÜNCHEN, May 04, 2025 (GLOBE NEWSWIRE) -- Boly Inc., ein globales Hightech-Unternehmen mit Hauptsitz im Silicon Valley, freut sich, auf der vom 7. bis 10. Mai in München stattfindenden Smart E Europe 2025 das revolutionäre Solarenergieprodukt BolySolar® 3D …

Les produits solaires concentrés haute performance de Boly entrent en phase de production de masse

Les produits solaires concentrés haute performance de Boly entrent en phase de production de masse

MUNICH, 04 mai 2025 (GLOBE NEWSWIRE) -- Boly Inc., une entreprise mondiale de haute technologie basée dans la Silicon Valley, est ravie d’annoncer le lancement de BolySolar® 3D, une innovation révolutionnaire dans le domaine de l’énergie solaire, à l’ …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service